Successful Treatment of Refractory Malignant Pleural Effusion in a Heavily Pre-treated Lung Adenocarcinoma Patient with <i>EGFR</i> Mutation Using a Combination of Erlotinib and Ramucirumab

Authors

Institutions

Publication Details

Journal
Haigan
Published
2024-12-20
DOI
https://doi.org/10.2482/haigan.64.929
Primary Topic
Pleural and Pulmonary Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful Treatment of Refractory Malignant Pleural Effusion in a Heavily Pre-treated Lung Adenocarcinoma Patient with EGFR Mutation Using a Combination of Erlotinib and Ramucirumab

Shinji Kakumoto, Kosuke Hamai, Masaaki Abe, Yu Nakanishi et al.
Haigan
Pleural and Pulmonary Diseases
article

Successful Treatment of Refractory Malignant Pleural Effusion in a Heavily Pre-treated Lung Adenocarcinoma Patient with EGFR Mutation Using a Combination of Erlotinib and Ramucirumab

Shinji Kakumoto, Kosuke Hamai, Masaaki Abe, Yu Nakanishi, Mako Tsuyuki
article en

Abstract

No abstract available for this paper.
HaiganVol. 64(7)
Hiroshima City Asa Citizens Hospital (JP), Hiroshima University Hospital (JP), North Medical Center (JP), Onomichi General Hospital (JP)
Good health and well-being
Openalex Percentile: Top 57%
Pleural and Pulmonary Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.